Skip to main content
TipRanks
Go Ultimate75% OFF

Terragen Holdings Ltd (TGH) AI Stock Analysis

1 Followers
AU:TGH

Terragen Holdings Ltd

(ASX:TGH)

Select Model
Rating:40Underperform
Price Target:AUD 0.01â–¼(-6.67% Downside)
Action:downgraded
Date:10/27/26

The overall score is very low, driven primarily by severe operational and cash flow distress. The company is deeply unprofitable with collapsing margins and negative cash flow, which is a critical risk to its viability. The balance sheet provides the only meaningful support, but it is being rapidly eroded by ongoing losses. Technicals confirm extreme weakness with the stock in a sustained downtrend and deeply oversold.

Positive Factors
Low LeverageVery low leverage reduces refinancing exposure and preserves financial flexibility compared with a highly indebted structure. This gives Terragen more capacity to manage operating volatility and potentially fund priorities without substantial fixed debt obligations.
Negative Factors
Persistent Cash BurnOngoing negative operating and free cash flow shows that the core business is not self-funding. Continued cash burn can consume available resources, increase reliance on external financing, and restrict investment capacity over the next several quarters.

Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)

-50%-40%-30%-20%-10%0%10%20%30%AU:TGH-37.50%EWA+10.71%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 7.04M
Dividend Yield
―
Average Volume (3M)
131.16K
Price to Earnings (P/E)
-2.4
Beta (1Y)
0.16
Revenue Growth
-11.34%
EPS Growth
30.34%
Country
Australia
Employees
15
Sector
Basic Materials
Sector Strength
61
Industry
Agricultural Inputs

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description

Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout Aus...

Terragen Holdings Ltd Financial Statement Overview

Summary

Financial performance is critically weak. The income statement shows collapsing margins and persistent net losses, and cash flow is deeply negative with the company burning through cash. The only support comes from a strong balance sheet with very low debt and a recently strengthened equity base, which provides a temporary buffer against operational distress.

Income Statement

18Very Negative

Balance Sheet

72Positive

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.43M1.43M1.62M2.14M3.28M2.89M
Gross Profit524.91K524.91K792.23K2.06M3.21M2.62M
EBITDA-4.09M-4.09M-4.53M-3.50M-3.46M-5.67M
Net Income-3.75M-3.75M-3.72M-3.01M-3.23M-5.41M
Balance Sheet
Total Assets10.59M10.59M8.12M6.95M6.35M9.22M
Cash, Cash Equivalents and Short-Term Investments7.36M7.36M4.81M4.54M4.17M6.67M
Total Debt275.57K275.57K735.45K542.23K239.37K332.26K
Total Liabilities1.09M1.09M1.55M1.63M1.27M1.46M
Stockholders Equity9.50M9.50M6.57M5.32M5.08M7.76M
Cash Flow
Free Cash Flow-3.49M-3.49M-3.03M-2.35M-2.91M-4.97M
Operating Cash Flow-3.38M-3.38M-3.03M-2.32M-2.81M-4.80M
Investing Cash Flow-176.70K-176.70K-682.43K-132.93K-35.20K-118.20K
Financing Cash Flow6.12M6.12M3.87M2.82M351.00K-52.70K

Terragen Holdings Ltd Technical Analysis

Technical Analysis SentimentPositive
Last Price0.01

Price Trends

50DMA0.02Positive
100DMA0.02Positive
200DMA0.02Positive

Market Momentum

MACD0.00Negative
RSI79.15Negative
STOCH175.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Positive. The current price of 0.01 is above the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 79.15 is Negative, neither overbought nor oversold. The STOCH value of 175.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

AU:TGH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
AU:NUFAU:NUF52NeutralAUD 1.18B-3.88-13.83%―-6.75%46.98%
AU:CP8AU:CP843NeutralAUD 51.29M-17.12-22.21%―-30.52%-19.67%
AU:AMNAU:AMN40UnderperformAUD 14.04M-7.50-6.36%――96.72%
AU:TGHAU:TGH40UnderperformAUD 12.35M-2.42-52.55%―-11.34%30.34%
AU:RLFAU:RLF38UnderperformAUD 16.65M-1.80-88.51%―-0.48%-195.74%

* Basic Materials Sector Average

Performance Comparison

0%100%200%300%AU:TGHAU:CP8AU:NUFAU:AMNAU:RLFAU:KM1Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:TGH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:TGHTerragen Holdings Ltd0.01-0.01-37.50%
AU:CP8Canadian Phosphate Limited0.130.09195.45%
AU:NUFNufarm Limited3.060.5923.89%
AU:AMNAgrimin Limited0.04-0.04-51.35%
AU:RLFRLF AgTech Ltd0.03-0.04-60.94%
AU:KM1Kali Metals Limited0.08-0.11-58.95%

Terragen Holdings Ltd Corporate Events

Terragen Advances Key Feedlot Trials and Secures Brazilian Export Approval

Oct 30, 2026

Terragen reported a solid operational quarter to 30 September 2026, advancing major feedlot trials with Mort & Co and Agriculture and Agri-Food Canada, and progressing a conditional supply agreement with Ravensworth Feedlot that is on track for first...

Terragen director Richard Norton steps down, retains indirect equity exposure

Oct 29, 2026

Terragen Holdings Ltd has announced that director Richard Norton ceased to be a director of the company on 28 October 2026, with a final disclosure of his relevant interests lodged under ASX listing rule 3.19A.3. While Norton held no securities in hi...

Terragen Names Interim CEO as CFO Withdraws Resignation

Oct 28, 2026

Terragen Holdings Limited has appointed Chief Operating Officer Dr Joss West as interim Chief Executive Officer, effective immediately, following earlier executive changes disclosed to the market. The company has also confirmed that Chief Financial O...

Terragen CEO Richard Norton Resigns as Board Launches Search for Successor

Oct 28, 2026

Terragen Holdings Ltd announced that Chief Executive Officer Richard Norton has resigned, effective 28 October 2026, marking a significant leadership change for the agritech company. The board publicly thanked Norton for his contributions during his...

Terragen Sets Virtual-Only AGM for 27 November 2026

Oct 26, 2026

Terragen Holdings Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. Melbourne time on Friday, 27 November 2026. The meeting will be conducted entirely online as a virtual-only event, with shareholders able to participate via the specifi...

Terragen discloses final director interest as Michele Allan departs board

Oct 20, 2026

Terragen Holdings Ltd has announced that Dr Michele Allan AO has ceased serving as a director of the company as of 16 October 2026, and lodged a final director’s interest notice with the ASX. The filing details that Dr Allan holds a total of 3.5 mill...

Terragen appoints fractional CFO after finance chief resigns

Oct 7, 2026

Terragen Holdings Limited has announced the resignation of Chief Financial Officer and Joint Company Secretary Daniel Pearce, effective immediately, and moved to an outsourced model for financial leadership. The company has engaged Traverse Accountan...

Terragen Sets Date and Nomination Process for 2026 AGM

Oct 2, 2026

Terragen Holdings Limited has scheduled its 2026 Annual General Meeting for Friday, 27 November 2026, with the election of directors to be included as an item of business. The company has outlined the timetable and process for director nominations an...

Terragen Details Compliance With ASX Corporate Governance Standards

Aug 25, 2026

Terragen Holdings Limited has detailed its corporate governance practices for the 2025–26 financial year, confirming alignment with the ASX Corporate Governance Council’s latest principles and recommendations. The board emphasises clear oversight of...

Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes

Aug 25, 2026

Terragen Holdings Limited, an agricultural biotechnology company, develops and markets biological products aimed at improving livestock and crop performance for farmers and agribusiness clients. Operating in a specialised agri-tech niche, the company...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 27, 2026